COLLEEN GAFFNEY: Open Payments
NPI 1295957579 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| CSL Behring | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $17 |
Products named: Rystiggo, INGREZZA, Hizentra, HYQVIA, ULTOMIRIS, Symbravo, VYEPTI.
Industry payments across MD — which companies pay providers there.
